Cost-Effectiveness Analysis of Ustekinumab and Adalimumab in Psoriatic Patients Previously Treated with Etanercept in a Real-World Setting
May 1, 2016, 00:00
10.1016/j.jval.2016.03.503
https://www.valueinhealthjournal.com/article/S1098-3015(16)00571-4/fulltext
Title :
Cost-Effectiveness Analysis of Ustekinumab and Adalimumab in Psoriatic Patients Previously Treated with Etanercept in a Real-World Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00571-4&doi=10.1016/j.jval.2016.03.503
First page :
A124
Section Title :
Sensory System Disorders - Cost Studies
Open access? :
No
Section Order :
157